Liberty Pharma Private Ltd.
About Liberty Pharma Private Ltd.
Data last updated: 06 March 2026
Liberty Pharma Private Ltd. is a private limited company based in Kolkata, West Bengal, India. It specialises in real estate financing, a part of the broader financial services sector. Incorporated on 03 May 1995, the company has been in operation for over 31 years.
Registered with ROC Kolkata under CIN U24231WB1995PLC071347.
Capital: an authorised share capital of ₹20 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Rajendra Kumar Jalan and Kulveer Hurkat.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Shrachitower 686 Anandapur E.M.Bypassr.B.Connectorjunction, Kolkata, West Bengal, India – 700107.
As per the financials filed for FY 2024, the company reported a revenue of ₹5,400, a decline of 40% compared to the previous year.
As per MCA filings, the company has open charges of ₹10.99 Cr and satisfied charges of ₹13.62 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressShrachitower 686 Anandapur E.M.Bypassr.B.Connectorjunction, Kolkata, West Bengal, India – 700107
-
IndustryFinancial Services, Real Estate Financing
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Liberty Pharma Private Ltd.
Liberty Pharma Private Ltd. has one previous CIN (Corporate Identification Number): U24231WB1995PLC071347. The current CIN is U24231WB1995PTC071347, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231WB1995PTC071347 | Current |
| U24231WB1995PLC071347 | Previous |
Business Activity of Liberty Pharma Private Ltd.
Liberty Pharma Private Ltd. is engaged in the principal business activity of real estate, with detailed activities including real estate activities with own or leased property.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| L | Real Estate | L1 | Real estate activities with own or leased property | ********* |
Board of Directors of Liberty Pharma Private Ltd.
Liberty Pharma Private Ltd. is currently managed by 2 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Kumar Jalan | Director | 20 Sep 2021 | 4 Years 9 Months | Current |
|
Kulveer Hurkat
Also directs:
Indraprastha Farms Pvt.Ltd., Nadia Printing & Packaging Pvt.Ltd., Kanaiya Engineering & Finance Private Limited and 5 more
|
Director | 31 Mar 2023 | 3 Years 3 Months | Current |
Financials of Liberty Pharma Private Ltd. FY 2025 filings available
Liberty Pharma Private Ltd. reported revenue of ₹5,400 (down 40% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Liberty Pharma Private Ltd.
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Dec 2021 | Others | ₹10.99 Cr | Open |
| 11 Oct 2017 | Others | ₹11.02 Cr | Satisfied |
| 10 Dec 2005 | Icici Bank Ltd. | ₹2.6 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Liberty Pharma Private Ltd.
View historical data on people associated with Liberty Pharma Private Ltd., including employment history and EPFO contributions.
Employee Count & EPFO Data of Liberty Pharma Private Ltd.
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Liberty Pharma Private Ltd.
GSTIN & GST Filing Data of Liberty Pharma Private Ltd.
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Liberty Pharma Private Ltd.
Credit Ratings, Legal Cases & Regulatory Alerts of Liberty Pharma Private Ltd.
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Liberty Pharma Private Ltd.
MSME Payment Delays by Liberty Pharma Private Ltd.
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Liberty Pharma Private Ltd.
Subsidiaries & Group Companies of Liberty Pharma Private Ltd.
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Liberty Pharma Private Ltd. with ownership details.
MCA Filings & Documents of Liberty Pharma Private Ltd.
MCA Filings & Documents of Liberty Pharma Private Ltd.
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Liberty Pharma Private Ltd.
Frequently Asked Questions about Liberty Pharma Private Ltd.
Liberty Pharma Private Ltd. is an active private limited company in the financial services sector based in Kolkata, West Bengal, India. It was incorporated on 03 May 1995 (31+ years old) and is registered under CIN U24231WB1995PTC071347.
Liberty Pharma Private Ltd. reported revenue of ₹5,400 for FY 2024 (down 40.00% YoY).
The current directors of Liberty Pharma Private Ltd. are:
The primary industry of Liberty Pharma Private Ltd. is financial services. The company specifically operates in real estate financing. The company is currently active in this sector.
Liberty Pharma Private Ltd. can be reached at the registered office: Shrachitower 686 Anandapur E.M.Bypassr.B.Connectorjunction, Kolkata, West Bengal, India – 700107.
The authorised capital is ₹20 Lakh, and the paid-up capital is ₹8 Lakh.